SP

Sean P. Nolan

North America, Illinois, United States, Chicago

Description

Sean P. Nolan is an accomplished executive with over 24 years of pharmaceutical industry experience that includes leadership roles in buildi...

Investor Profile

Sean P. Nolan has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Genetics, Product Research.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Product Research
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sean P. Nolan frequently co-invest with?

Goldman Sachs
North America, New York, United States, New York
Co-Investments: 1
Deerfield
North America, New York, United States, New York
Co-Investments: 1
Nolan Capital
North America, California, United States, Hermosa Beach
Co-Investments: 1
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 1
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by Sean P. Nolan?

Jaguar Gene Therapy

Lake Forest, Illinois, United States

Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.

BiotechnologyGeneticsProduct Research
Series BApr 13, 2021
Amount Raised: $139,000,000